Product/Technology/Company Valuation
Value is fundamentally determined by trade, the relationship between supply and demand. Future cash flow is important, but it is by no means the only determinant of value in deal situation. In order to understand the value of a new product or technology, or a company, two knowledge assets are prerequisite: expertise in value assessment and modelling techniques, and industry insight into the drivers behind senior management decisions. PharmaVentures is an industry leader in asset valuation. We have conducted a large number of life sciences product/technology/company valuations facing high market uncertainty.
Product / Technology / Company Valuation Diagram
©PharmaVentures 2008, Click image to enlarge
Beyond our expert knowledge of valuation techniques, our key strength is our proprietary deals database – PharmaDeals® Agreements – which provides us with details of comparables and deal structures. This source is used to generate evidence on trends in trade, and supports research that goes beyond the reported deals and contracts themselves. Deals cannot be struck without careful valuation of what the parties bring to the table, and PharmaVentures helps our clients in that challenge.